Dems pressure Biden to share Moderna vaccine tech
14-10-2021
Moderna’s COVID-19 and Zika patent applications to be investigated
08-09-2020
Moderna unsure of COVID-19 vaccine patent exclusivity
12-08-2020
Ascannio / Shutterstock.com
Biopharmaceutical company, Moderna, has announced that it will not enforce patents related to its COVID-19 vaccine while the pandemic is ongoing, and that it is prepared to license the patents to others after the pandemic is over.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Moderna, COVID-19, vaccine, biopharmaceutical, IP, patents, BARDA, DARPA, Knowledge Ecology International, World Health Organization, USPTO
